Skip to main content

DMK Pharmaceuticals Corp

DMKDelisted Mar 21, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000887247

DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.

Holders of 5% or more of DMK

Holders whose latest Schedule 13D or 13G filing reports 5% or more of DMK Pharmaceuticals Corp, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of DMK Pharmaceuticals Corp on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on DMK Pharmaceuticals Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on DMK
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 6, 2024Intracoastal Capital, LLC13G/AOld format–––SEC
Sep 26, 2023Versi Group LLC13D/AOld format–––SEC
Aug 10, 2023Intracoastal Capital, LLC13GOld format–New–SEC
Jun 5, 2023Versi Group LLC13DOld format–New–SEC
Feb 16, 2021CVI Investments, Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell DMK Pharmaceuticals Corp shares.

No Form 144 notices for DMK Pharmaceuticals Corp are on file.